Contact
Contact

“At QUIDDITAS, our team is driven by a shared commitment to scientific excellence and integrity. We bring together diverse expertise, united by a dedication to advancing our mission and delivering meaningful impact through innovation.”

François Cherbonneau

CEO and Co-founder

Management

Our Management Team steers QUIDDITAS’ vision and day‑to‑day execution. Focused on science, strategy and delivery, the team drives the development of the GREAT platform and coordinates the partnerships that support our next stages of growth.

François Cherbonneau, Ph.D.

CEO and co-founder

Aurore Cherbonneau Prunevieille, Ph.D.

COO and co-founder

Board

Our Board brings strategic perspective and long‑term guidance to QUIDDITAS. With broad experience across biotech and company building, the Board helps keep us focused on priorities, execution, and delivering long‑term value for patients.

François Cherbonneau, Ph.D.

CEO and co-founder

Aurore Cherbonneau Prunevieille, Ph.D.

COO and co-founder

Mathieu Simon, MD

Independent Member of the Board – Vice-Chairman and Lead Independent Director at Idorsia

Emmanuel Leonard

Member of the Board – Investor Key Ventures

Georges Rawadi, Ph.D.

Chairman of the Board – CEO StromaCare

Laurent Bracco, Ph.D.

Member of the Board – Investor in Life Sciences

Jean Pierre Kinet, MD

Member of the Board – Managing Partner iXLife Capital

Scientific Advisory Board (SAB)

Our Scientific Advisory Board gathers leading experts in genome engineering and gene therapy to support the scientific direction of the GREAT platform.
Full SAB profiles will be published soon.